Maricann Gets New License to Increase Annual Cannabis Production

Maricann Group (CSE:MARI; OTCQB:MRRCF) announced Health Canada granted the company a new license set to remove their annual production limits of medical cannabis from their Langton, Ontario facility.
As quoted in the press release:

This new licence increases capacity to 6,250,000 grams on site at any one time. This is an increase from its previous annual licence that limited production to a total of 1,282,000 grams (930kg of dried marihuana and 352 kg of cannabis oil) per year. This new license represents an increase of over 480% of production capacity and is valid until October 9, 2020. Maricann’s new facility will house an additional two vaults with 30,000,000 grams of potential licensed storage capacity (15,000,000 grams each).
“This new license gives us more flexibility as we are able to increase production volume and provide more bulk storage for cannabis products, including processed resin to meet future demand,” said Ben Ward, CEO of Maricann. “With the Phase 1 expansion of our state of the art Langton cultivation and production facility nearing completion and with both new vaults now poured and in place, we expect to be able to take full advantage of the scale we are creating. We maintain a highly secure growing environment that meets or exceeds requirements of the Access to Cannabis for Medical Purposes Regulations (ACMPR).”

Click here to read the full press release.

Source: www.marketwired.com